AGM/EGMApr 29, 2026, 04:46 PM
OFIX 2026 Annual Meeting Set for June 10; Key Proposals & 2025 Highlights
AI Summary
Orthofix Medical Inc. announced its 2026 Annual Meeting of Shareholders will be held on June 10, 2026, in Plano, Texas, with a record date of April 13, 2026. Shareholders will vote on the election of directors, executive compensation, ratification of EY as auditor, and an amendment to the stock purchase plan. The definitive proxy statement also highlighted 2025 financial performance, including $822.3 million in net sales and a $(92.2) million net loss, alongside details on corporate governance and executive compensation practices. Max Reinhardt, President of Global Spine, is set to depart around June 12, 2026.
Key Highlights
- 2026 Annual Meeting of Shareholders scheduled for June 10, 2026.
- Shareholders to vote on director elections, executive compensation, auditor, and stock plan.
- Max Reinhardt, President of Global Spine, to depart around June 12, 2026.
- 2025 net sales reached $822.3 million, a 2.9% increase year-over-year.
- Reported net loss for 2025 was $(92.2) million.
- Non-GAAP pro forma adjusted EBITDA was $85.9 million, or 10.6% of sales.
- Global Spine Fixation net sales grew 10.1% in 2025.
- Bone Growth Therapies net sales grew 5.9% to $247.2 million.